Cargando…
273 Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab—Case Report
BACKGROUND: Pregnancy may aggravate asthma and result in life-threatening for both mother and foetus. The humanized monoclonal antibody omalizumab has proven to be effective in controlling severe asthma. The purpose of this case report is to present the effectiveness and safety of this medicine duri...
Autores principales: | Kuschnir, Fábio, Emerson, Fatima, Cordeiro, Nelson, Rocha, Michele Viegas, Filho, Silvio Lima, Rios, Jose Luiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513155/ http://dx.doi.org/10.1097/01.WOX.0000412030.62254.93 |
Ejemplares similares
-
360 Effects of Omalizumab in Children with Atopic Keratocojunctivitis: A New Treatment for Severe Ocular Allergies?—Report of Two Cases
por: Kuschnir, Fábio, et al.
Publicado: (2012) -
279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012) -
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
por: Bergmann, Karl-Christian, et al.
Publicado: (2012) -
270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012) -
272 Gender and Different Prevalence in Asthma Treatment With Anti-IGE (Omalizumab)
por: Patella, Vincenzo, et al.
Publicado: (2012)